Skip to main content

Find Clinical Trials

Clinical trial condition

mCRC

Explore clinical trials studying mCRC. Study availability and eligibility vary by location and protocol.

8 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

mCRC trial results

Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

NCT07446322

Conditions: MSS Metastatic Colorectal Cancer, Ras-mutated Metastatic Colorectal Cancer, mCRC
Locations: Central Alabama Research Homewood, Alabama, United States

Clinical Research Advisors (Beverly Hills) Beverly Hills, California, United States

Clinical Research Advisors (Encino) Encino, California, United States

Clinical Research Advisors (Korea Town) Koreatown, California, United States

View all 13 locations

View Trial Details

Recruiting

"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"

NCT06829355

Conditions: mCRC
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, China

View Trial Details

Not Yet Recruiting

A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer

NCT07543471

Conditions: mCRC
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer

NCT07502014

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

MA-CRC-II-016 SHR-1811

NCT07355764

Conditions: Antibody-drug Conjugates, HER2, Targeted Therapy, +1 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

NCT07116577

Conditions: mCRC
Locations: Jinan Central Hospital Jinan, Shandong, China

View Trial Details

Completed

LifePearl-Iri Pharmacokinetic Study

NCT02547480

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations: KUL Leuven, Belgium

SLK-Kliniken Heilbronn GmbH Heilbronn, Germany

Klinikum Bogenhausen, Städt. Klinikum München GmbH Munich, Germany

View Trial Details

Active, Not Recruiting

Phase I PK Comparison of HLX05 vs. Erbitux® in Healthy Chinese Males: Safety, Immunogenicity, and Pharmacokinetics

NCT06980454

Conditions: Cancer, Neoplasms, mCRC
Locations: Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Xuzhou, Jiangsu, China

Affiliated Hospital of Xuzhou Medical University Jiangsu, Xuzhou, China

View Trial Details